Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2009 Sep 30;4(9):e7236.
doi: 10.1371/journal.pone.0007236.

Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study

Trine Welløv Boesgaard  1 , Anette Prior Gjesing, Niels Grarup, Jarno Rutanen, Per-Anders Jansson, Marta Letizia Hribal, Giorgio Sesti, Andreas Fritsche, Norbert Stefan, Harald Staiger, Hans Häring, Ulf Smith, Markku Laakso, Oluf Pedersen, Torben Hansen; EUGENE2 Consortium
Affiliations
Meta-Analysis

Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study

Trine Welløv Boesgaard et al. PLoS One. .

Abstract

Background: A meta-analysis combining results from three genome-wide association studies and followed by large-scale replication identified six novel type 2 diabetes loci. Subsequent studies of the effect of these variants on estimates of the beta-cell function and insulin sensitivity have been inconclusive. We examined these variants located in or near the JAZF1 (rs864745), THADA (rs7578597), TSPAN8 (rs7961581), ADAMTS9 (rs4607103), NOTCH2 (rs10923931) and the CDC123/CAMK1D (rs12779790) genes for associations with measures of pancreatic beta-cell function and insulin sensitivity.

Methodology/results: Oral and intravenous glucose stimulated insulin release (n = 849) and insulin sensitivity (n = 596) estimated from a hyperinsulinemic euglycemic clamp were measured in non-diabetic offspring of type 2 diabetic patients from five European populations. Assuming an additive genetic model the diabetes-associated major C-allele of rs4607103 near ADAMTS9 associated with reduced insulin-stimulated glucose uptake (p = 0.002) during a hyperinsulinemic euglycemic clamp. However, following intravenous and oral administration of glucose serum insulin release was increased in individuals with the C-allele (p = 0.003 and p = 0.01, respectively). A meta-analyse combining clamp and IVGTT data from a total of 905 non-diabetic individuals showed that the C-risk allele associated with decreased insulin sensitivity (p = 0.003) and increased insulin release (p = 0.002). The major T-allele of the intronic JAZF1 rs864745 conferring increased diabetes risk was associated with increased 2(nd) phase serum insulin release during an IVGTT (p = 0.03), and an increased fasting serum insulin level (p = 0.001). The remaining variants did not show any associations with insulin response, insulin sensitivity or any other measured quantitative traits.

Conclusion: The present studies suggest that the diabetogenic impact of the C-allele of rs4607103 near ADAMTS9 may in part be mediated through decreased insulin sensitivity of peripheral tissues.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Estimates of effects for the diabetes-associated major C-allele of rs4607103 near ADAMTS9 (based on log transformed traits and adjusted for sex, age and BMI) of the variants with 95% confidence.
A) M value; B) Disposition Index; C) 1st phase insulin secretion and D) 2nd phase insulin secretion. The black diamonds represent the combined and weight (using the DerSimonian-Laird method) effects of the studies. The grey diamonds represent the combined and weight (using inverse variance) effects of the studies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sladek R, Rocheleau G, Rung J, Dina C, Shen L. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–885. - PubMed
    1. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jansdottir T. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39:770–775. - PubMed
    1. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y. A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants. Science. 2007;316:1341–1345. - PMC - PubMed
    1. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS. Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes. Science. 2007;316:1336–1341. - PMC - PubMed
    1. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PIN. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels. Science. 2007;316:1331–1336. - PubMed

Publication types

  NODES
admin 1
Association 9
twitter 2